Emergent BioSolutions Announces Retirement of Richard Lindahl as CFO

Lindahl will continue to support the company as a senior executive advisor from January 1 to March 31, 2027, to help ensure a smooth transition.

Before joining Emergent in 2018, Rich served as CFO of CEB, senior vice president and treasurer at Sprint Nextel, and vice president of finance at Pocket Communications.

He also held several roles at MCI Communications and Deloitte & Touche. He currently serves on the board of Compass Therapeutics.

Read More:Opsin Secures $21M in Funding Led by SYN Ventures

The leadership change comes as Emergent continues its long-term plan to strengthen its business, improve operations and support sustainable growth.

“During my nearly nine years at Emergent, I am proud of the contributions our team made to the Company’s growth, the resilience we demonstrated through some extraordinarily challenging periods, and the progress we made in strengthening the business for the future,” said Lindahl.

“On behalf of the Board of Directors and our colleagues, I want to thank Rich for his exceptional leadership, partnership and commitment to Emergent, and importantly, his dedication to our mission to protect and save lives,” said Joe Papa, president and chief executive officer of Emergent.

About Emergent BioSolutions

Founded in 1998, Emergent BioSolutions develops products to protect public health and save lives. The company provides solutions to address health threats such as smallpox, mpox, botulism, Ebola, anthrax and opioid overdoses.

Read More:Syncra Announces Partnership with Neumetry Medical